Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients-Reference-Cited by-同舟云学术

Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients

Published:2022-02-27 Issue:7 Volume:29 Page:4376-4385
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Voss Rachel K.,Callegaro Dario,Chiang Yi-Ju,Fiore Marco,Miceli Rosalba,Keung Emily Z.,Feig Barry W.,Torres Keila E.,Scally Christopher P.,Hunt Kelly K.,Gronchi Alessandro,Roland Christina L.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-022-11442-2.pdf

Reference22 articles.

1. Smith HG, Memos N, Thomas JM, Smith MJ, Strauss DC, Hayes AJ. Patterns of disease relapse in primary extremity soft-tissue sarcoma. Br J Surg. 2016;103(11):1487–96.

2. Brennan MF, Antonescu CR, Moraco N, Singer S. Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg. 2014;260(3):416–21 (discussion 421–412).

3. Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003;97(10):2530–43.

4. Rueten-Budde AJ, van Praag VM, studygroup P, van de Sande MAJ, Fiocco M. Dynamic prediction of overall survival for patients with high-grade extremity soft tissue sarcoma. Surg Oncol. 2018;27(4):695–701.

5. Callegaro D, Miceli R, Bonvalot S, et al. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncol. 2016;17(5):671–80.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multimodal neural network with gradient blending improves predictions of survival and metastasis in sarcoma;npj Precision Oncology;2024-09-05

2. Setting the international research agenda for sarcomas with patients and carers: results of phase II of the Sarcoma Patient Advocacy Global Network (SPAGN) priority setting partnership;BMC Cancer;2024-08-06

3. Opportunities and Challenges in Soft Tissue Sarcoma Risk Stratification in the Era of Personalised Medicine;Current Treatment Options in Oncology;2024-07-30

4. Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wall;Cancer Medicine;2024-07

5. Management of soft tissue sarcomas of the chest wall: a comprehensive overview;Journal of Thoracic Disease;2024-05